An In Vivo Microdialysis Study of FLZ Penetration through the Blood-Brain Barrier in Normal and 6-Hydroxydopamine Induced Parkinson's Disease Model Rats

FLZ (N-[2-(4-hydroxy-phenyl)-ethyl]-2-(2,5-dimethoxy-phenyl)-3-(3-methoxy-4-hydroxy-phenyl)-acrylamide) is a novel synthetic squamosamide derivative and a potential anti-Parkinson's disease (PD) agent. The objective of the present study was to investigate the penetration of free FLZ across the...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Jinfeng, Liu, Qian, Li, Yingfei, Sun, Hua, Zhang, Jinlan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4090575/
https://www.ncbi.nlm.nih.gov/pubmed/25045708
http://dx.doi.org/10.1155/2014/850493

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4090575/
https://www.ncbi.nlm.nih.gov/pubmed/25045708
http://dx.doi.org/10.1155/2014/850493

Ejemplares similares